Literature DB >> 9593053

Mixed backbone oligonucleotides: improvement in oligonucleotide-induced toxicity in vivo.

S Agrawal1, Q Zhao.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9593053     DOI: 10.1089/oli.1.1998.8.135

Source DB:  PubMed          Journal:  Antisense Nucleic Acid Drug Dev        ISSN: 1087-2906


× No keyword cloud information.
  11 in total

1.  MicroRNA-feedback loop as a key modulator of liver tumorigenesis and inflammation.

Authors:  Angélique Gougelet; Sabine Colnot
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

2.  The urokinase plasminogen activator receptor (UPAR) is preferentially induced by nerve growth factor in PC12 pheochromocytoma cells and is required for NGF-driven differentiation.

Authors:  R Farias-Eisner; L Vician; A Silver; S Reddy; S A Rabbani; H R Herschman
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

3.  Antitumor activity and pharmacokinetics of a mixed-backbone antisense oligonucleotide targeted to the RIalpha subunit of protein kinase A after oral administration.

Authors:  H Wang; Q Cai; X Zeng; D Yu; S Agrawal; R Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

4.  A genomic-scale view of the cAMP response element-enhancer decoy: a tumor target-based genetic tool.

Authors:  Yee Sook Cho; Meyoung-Kon Kim; Chris Cheadle; Catherine Neary; Yun Gyu Park; Kevin G Becker; Yoon S Cho-Chung
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-18       Impact factor: 11.205

5.  Targeting the Mycobacterium tuberculosis 30/32-kDa mycolyl transferase complex as a therapeutic strategy against tuberculosis: Proof of principle by using antisense technology.

Authors:  Günter Harth; Marcus A Horwitz; David Tabatadze; Paul C Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-11       Impact factor: 11.205

6.  Inhibition of MDR1 gene expression by chimeric HNA antisense oligonucleotides.

Authors:  Hyunmin Kang; Michael H Fisher; Dong Xu; Yuko J Miyamoto; Arnaud Marchand; Arthur Van Aerschot; Piet Herdewijn; Rudolph L Juliano
Journal:  Nucleic Acids Res       Date:  2004-08-17       Impact factor: 16.971

7.  Reversal of cystic fibrosis phenotype in a cultured Delta508 cystic fibrosis transmembrane conductance regulator cell line by oligonucleotide insertion.

Authors:  Paul C Zamecnik; Malay K Raychowdhury; David R Tabatadze; Horacio F Cantiello
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-17       Impact factor: 11.205

8.  Comparison of different antisense strategies in mammalian cells using locked nucleic acids, 2'-O-methyl RNA, phosphorothioates and small interfering RNA.

Authors:  Arnold Grünweller; Eliza Wyszko; Birgit Bieber; Ricarda Jahnel; Volker A Erdmann; Jens Kurreck
Journal:  Nucleic Acids Res       Date:  2003-06-15       Impact factor: 16.971

9.  Hyperstable U1snRNA complementary to the K-ras transcripts induces cell death in pancreatic cancer cells.

Authors:  K Kato; Y Hitomi; K Imamura; H Esumi
Journal:  Br J Cancer       Date:  2002-10-07       Impact factor: 7.640

10.  Improvements in siRNA properties mediated by 2'-deoxy-2'-fluoro-beta-D-arabinonucleic acid (FANA).

Authors:  Thomas Dowler; Denis Bergeron; Anna-Lisa Tedeschi; Luc Paquet; Nicolay Ferrari; Masad J Damha
Journal:  Nucleic Acids Res       Date:  2006-03-22       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.